Oura valued at $5B following deal with medical device firm Dexcom
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
Wareable4h
Oura and Dexcom go big on CGMs with $75m partnership
Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...
CNET5h
Oura Rings Will Soon Work With Dexcom to Connect the Dots Between Activity, Food and Blood Sugar
Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...
Barchart on MSN1d
Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?
Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...
People without diabetes can use continuous glucose monitors. But should they?
CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...
Science Talk: Helping people manage diabetes through technology and research
With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...
CNET2d
Lingo CGM Review: I've Sweetened on the Idea Everybody Should Track Their Blood Sugar
Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.
drugdeliverybusiness5d
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Business Wire5d
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...